ANACOR PHARMACEUTICALS INC COM
ANAC
ANAC was delisted on the 23rd of June, 2016.
2 hedge funds and large institutions have $5.74M invested in ANACOR PHARMACEUTICALS INC COM in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 195 closing their positions.
133% more call options, than puts
Call options by funds: $14K | Put options by funds: $6K
99% less funds holding
Funds holding: 199 → 2 (-197)
99% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 195
100% less capital invested
Capital invested by funds: $2.48B → $5.74M (-$2.48B)
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIM
CIM Investment Management
Pittsburgh,
Pennsylvania
|
+$273K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$360M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$274M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$154M |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$119M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$95.4M |
ANAC Hedge Fund Activity: Q2 2016 in Review
2 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q2 2016, worth a combined $5.74M — down 100% from $2.48B a quarter earlier.
Sellers outnumbered buyers: 195 funds closed out of ANAC and 1 opened new positions — a net loss of 194 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was CIM Investment Management, opening a new position worth an estimated $273K. The largest seller was Fidelity Investments, exiting entirely with an estimated $360M sold.
- 2 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q2 2016, down from 199 in Q1 2016.
- Funds reported $5.74M of ANACOR PHARMACEUTICALS INC COM stock for Q2 2016, down 100% quarter-over-quarter.
- 1 fund opened new ANACOR PHARMACEUTICALS INC COM positions in Q2 2016 and 195 closed out, a net change of -194 holders.
- The largest ANACOR PHARMACEUTICALS INC COM buyer in Q2 2016 was CIM Investment Management, an estimated $273K added.
- The largest ANACOR PHARMACEUTICALS INC COM seller in Q2 2016 was Fidelity Investments, an estimated $360M sold.
Based on aggregated 13F filings for Q2 2016.